Skip to main content
Equibles

Jump Financial, LLC

Position in CRVS — Corvus Pharmaceuticals, Inc.

CIK 1831577 Chicago, IL
Back to CRVS Full portfolio

Position in CRVS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$4,682,196
+$2,519,151 QoQ
Shares Held
313,400
+112.0% QoQ
Ownership
0.373%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRVS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Jump Financial, LLC holds $441,725,895 across 169 Biotechnology names. CRVS ranks #29 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 306,330 $24,288,904
2 VKTX
Viking Therapeutics, Inc.
 579,882 $22,621,196
3 XENE
Xenon Pharmaceuticals Inc.
 260,730 $15,737,662
4 CRSP
CRISPR Therapeutics AG
 277,952 $15,159,500
5 BMRN
Biomarin Pharmaceutical Inc
 245,390 $14,041,214
6 SRPT
Sarepta Therapeutics, Inc.
 679,445 $12,209,626
7 REGN
Regeneron Pharmaceuticals, Inc.
 16,242 $10,127,536
8 RARE
Ultragenyx Pharmaceutical Inc.
 286,952 $9,581,327

All Filings in CRVS

Export CSV
4 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,682,196 313,400
2026-03-31 $2,163,045 147,850
2025-03-31 $143,141 45,013
2021-12-31 $133,755 55,500